25年来在中国和美国药品和医疗器械领域，从产品研发到上市的生命周期管理方面的经验。她熟悉国内创新药公司和跨国企业的运作 。她曾任昆泰大中华区首席医学管。成功主导过多项新药临床开发项目。在医学、临床运营、方案设计等方面拥有丰富经验。她曾在法国皮尔法伯制药、Parexel等外资制药企业和CRO担任亚太临床和医学负责人。也曾担任中国临床肿瘤学会 (CSCO) 临床研究和药物安全委员会委员.

参加编审多本医学书籍、撰写并发表SCI文章，曾任CMAO（中华医学事务）医学联络官专委会主席

张医生毕业于上海交通大学医学院并在英国卡的夫商学院获得工商管理学硕士（MBA）。她曾在临床呼吸内科工作。在美国印第安纳州大学医学中心工作了4年,于2006年回国后一直从事临床研发和医学事务工作。

Helena, MD, MBA is the Chief Medical Officer (CMO) of Convalife.

Dr. Zhang joined the biopharmaceutical industry in 1996 and had gained a wealth of experience on product life-cycle management both in the field of drug and medical device in China and US. She was the Chief Medical Officer for Quintiles, now IQVIA in the Greater China region. She is familiar with the operation of domestic innovative drug companies and multinational companies. She has successfully led a number of new drug clinical development projects. Her rich experiences cover medical, clinical operation and study design etc. She served as the head of clinical and medical of Asia Pacific region in MNC pharmaceutical company and CRO such as Pierre Fabre medicament and Parexel. She also served as the key board member of the clinical research and drug safety committee of the Chinese Society of Clinical Oncology (CSCO).

She wrote and published SCI papers, and served as the Chairman of Medical Science Liaison Committee, CMAO (Chinese Medical Affairs Organization)

Dr. Zhang graduated from the medical school of Shanghai Jiaotong University and obtained a master of Business Administration (MBA) from Cardiff Business School in the UK. She practiced clinical medicine in the hospital. She worked in the medical center of Indiana University, US for four years and has been engaged in clinical development and medical affairs since returning home in 2006.